MicroRNA-687 induced by hypoxia-inducible factor-1 targets phosphatase and tensin homolog in renal ischemia-reperfusion injury

100Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Ischemia-reperfusion injury contributes to tissue damage and organ failure in clinical settings, but the underlying mechanismremains elusive and effective therapies are still lacking. Here, we identified microRNA 687 (miR-687) as a key regulator and therapeutic target in renal ischemia-reperfusion injury.We show thatmiR-687 is markedly upregulated in the kidney during renal ischemia-reperfusion in mice and in cultured kidney cells during hypoxia. MiR-687 induction under these conditionswasmediated by hypoxia-inducible factor-1 (HIF-1).Upon induction in vitro, miR-687 repressed the expression of phosphatase and tensin homolog (PTEN) and facilitated cell cycle progression and apoptosis. Blockade of miR-687 preserved PTEN expression and attenuated cell cycle activation and renal apoptosis, resulting in protection against kidney injury in mice. Collectively, these results unveil a novel HIF-1/miR-687/PTEN signaling pathway in ischemia-reperfusion injury that may be targeted for therapy.

Cite

CITATION STYLE

APA

Bhatt, K., Wei, Q., Pabla, N., Dong, G., Mi, Q. S., Liang, M., … Dong, Z. (2015). MicroRNA-687 induced by hypoxia-inducible factor-1 targets phosphatase and tensin homolog in renal ischemia-reperfusion injury. Journal of the American Society of Nephrology, 26(7), 1588–1596. https://doi.org/10.1681/ASN.2014050463

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free